文献速递心血管US

经皮二尖瓣成形术后二尖瓣反流:机制及其对临床结局影响的深入分析

Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-09-16

本研究前瞻性纳入344例接受经皮二尖瓣成形术的二尖瓣狭窄患者,用定量超声心动图评估反流严重程度,并用三维经食管超声心动图将反流机制分为4类。术后显著二尖瓣反流发生率为18.6%,最常见的机制为交界处撕裂;交界处反流或轻度反流者预后较好,而中央瓣叶扇区或瓣下结构损伤者1年无事件生存率仅7%。

要点

  • 术后显著二尖瓣反流见于18.6%的患者,最常见机制为交界处撕裂(34.4%)。
  • 中央瓣叶扇区或瓣下结构损伤者预后最差,1年无事件生存率仅7%。
  • 基线净房室顺应性和术后瓣口面积、平均跨瓣压差及脑钠肽下降幅度可预测长期结局。

关键影像表现/征象

  • 术后显著二尖瓣反流64例(18.6%),机制以交界处撕裂最常见(22例,34.4%),其次为交界处合并后叶损伤(16例,25.0%)、瓣叶中央扇区或瓣下结构损伤(15例,23.4%)及中央性反流(11例,17.2%)。
  • 轻度或交界处反流患者的无事件生存率相似,而中央瓣叶扇区或瓣下结构损伤者结局最差,1年无事件生存率仅7%。
  • 平均随访3年(范围1天至10.6年)期间,60例患者达到终点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to assess the incidence, mechanisms, and outcomes of mitral regurgitation (MR) after percutaneous mitral valvuloplasty (PMV).

BACKGROUND: Significant MR continues to be a major complication of PMV, with a wide range in clinical presentation and prognosis.

METHODS: Consecutive patients with mitral stenosis undergoing PMV were prospectively enrolled. MR severity was evaluated by using quantitative echocardiographic criteria, and its mechanism was characterized by 3-dimensional transesophageal echocardiography, divided broadly into 4 categories based on the features contributing to the valve damage. B-type natriuretic peptide levels were obtained before and 24 h after the procedure. Endpoints estimated cardiovascular death or mitral valve (MV) replacement due to predominant MR.

RESULTS: A total of 344 patients, ages 45.1 ± 12.1 years, of whom 293 (85%) were women, were enrolled. Significant MR after PMV was found in 64 patients (18.6%). The most frequent mechanism of MR was commissural, which occurred in 22 (34.4%) patients, followed by commissural with posterior leaflet in 16 (25.0%), leaflets at central scallop or subvalvular damage in 15 (23.4%), and central MR in 11 (17.2%). During the mean follow-up period of 3 years (range 1 day to 10.6 years), 60 patients reached the endpoint. The event-free survival rates were similar among patients with mild or commissural MR, whereas patients with damaged central leaflet scallop or subvalvular apparatus had the worst outcome, with an event-free survival rate at 1 year of only 7%. Long-term outcome was predicted by net atrioventricular compliance (Cn) at baseline and post-procedural variables, including valve area, mean gradient, and magnitude of decrease in B-type natriuretic peptide levels, adjusted for the mechanism of MR.

CONCLUSIONS: Significant MR following PMV is a frequent event, mainly related to commissural splitting, with favorable clinical outcome. Parameters that express the relief of valve obstruction and the mechanism by which MR develops were predictors of long-term outcomes.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Nunes MCP, Levine RA, Braulio R, et al. Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes. JACC Cardiovasc Imaging. 2020. PMID: 32950446. doi:10.1016/j.jcmg.2020.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。